Elise Gradhand

An Illegitimate microRNA Target Site within the 3′ UTR of <i>MDM4</i> Affects Ovarian Cancer Progression and Chemosensitivity

Jessika Wynendaele, Anja Böhnke, Eleonora Leucci et al. · Cancer Research · 2010 · 166 citations · Full text

Life Sciences, Genetics, Oncology +15

Ezrin Promotes Ovarian Carcinoma Cell Invasion and Its Retained Expression Predicts Poor Prognosis in Ovarian Carcinoma

Martin K bel, Elise Gradhand, Katharina Zeng et al. · International Journal of Gynecological Pathology · 2006 · 72 citations

Medicine, Cell Biology, Oncology +15

Both Germ Line and Somatic Genetics of the p53 Pathway Affect Ovarian Cancer Incidence and Survival

Frank Bartel, Juliane Jung, Anja Böhnke et al. · Clinical Cancer Research · 2008 · 67 citations

Medicine, Genetics, Oncology +15

First report from the German COVID-19 autopsy registry

Saskia von Stillfried, Roman D. Bülow, Rainer Röhrig et al. · The Lancet Regional Health - Europe · 2022 · 66 citations · Full text

Medicine, Infectious Diseases, Pathology +9

Altered tumor formation and evolutionary selection of genetic variants in the human MDM4 oncogene

Gurinder S. Atwal, Tomas Kirchhoff, Elisabeth E. Bond et al. · Proceedings of the National Academy of Sciences · 2009 · 64 citations · Full text

Medicine, Genetics, Molecular Genetics +14